Clinical Trial Update: Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge [Phase 4]

View source ↗

Summary

This update reports on the duration of bronchoprotection provided by a Long Acting Muscarinic Antagonist during methacholine challenge in a Phase 4 asthma trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: University of Saskatchewan | Conditions: Asthma | Phase 4 | Status: COMPLETED